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INTRODUCTION
Kidney transplantation (KTx) remains the treatment of 
choice for patients with end-stage kidney disease and 
early postoperative assessment of KTx vascularization is 
warranted. Ultrasound is the imaging modality of choice 
according to the Kidney Disease: Improving Global 
Outcomes (KDIGO) clinical practice guideline for the care 
of kidney transplant recipients, as it is noninvasive, less 
Kidney Transplantation
Background. Doppler ultrasound, including intrarenal resistance index (RI) measurement, is a widely used modality to 
assess kidney transplantation (KTx) vascularization. The aim of this study is to gain insight in the associations between early 
postoperative RI measurements and cardiovascular events (CVEs), all-cause mortality, and death-censored graft survival. 
Methods. From 2015 to 2017, a prospective cohort study was conducted in patients in which RI measurement was per-
formed immediately after KTx. The RI was calculated as (peak systolic velocity—end-diastolic velocity)/peak systolic velocity. 
End points were CVEs, all-cause mortality, and graft failure. Kaplan-Meier analyses (logrank test) were used for differences 
in end points. Univariate and multivariate associations were investigated by means of Cox regression analyses. Results. 
RI cutoff of 0.70 was used. We included 339 recipients, of which 271 (80%) had an RI ≤ 0.70 and 68 (20%) had an RI > 0.70. 
CVEs were observed in 27 (8%) patients, 27 (8%) patients died, and 17 (5%) patients had graft failure during a median follow-
up of 37 months (interquartile range, 33–43). Kaplan-Meier analyses and univariate Cox regression indicated a significant 
association with overall CVE-free survival (hazard ratios [HR], 2.79; P = 0.011; logrank test, P = 0.008) and all-cause mortality 
(HR, 2.59; P = 0.017; logrank test, P = 0.013) for patients with an RI above and below 0.70. An independent association was 
shown between an RI > 0.70 and CVE-free survival (HR, 2.48; P = 0.042) when deceased donation was not included in the 
model. Conclusions. In the early postoperative period, a high RI showed to be associated with CVEs after adjustment 
for cardiovascular risk factors, whereas no independent association was found with overall survival and graft failure. For the 
interpretation of RI measurements after KTx surgery, patients’ cardiovascular state should be taken into consideration.
(Transplantation Direct 2020;6: e581; doi: 10.1097/TXD.0000000000001034. Published online 15 July, 2020.)
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expensive compared with other imaging modalities, and 
does not require the administration of contrast agents.1–3 
The intrarenal resistance index (RI) is one of the routinely 
assessed parameters during postoperative ultrasound, and 
it reflects the vascular flow in the renal arteries, distal to 
the point of measurement.1 However, the clinical implica-
tion of the RI remains unclear, and little is known about 
the clinical factors that influence RI measurements.
A previous study concluded that an increased RI in KTx 
recipients is associated with adverse long-term patient and 
graft outcomes.4 Subsequent analyses revealed that an 
increased RI is a reflection of characteristics of the transplant 
recipient rather than of the vascular condition of the graft.5,6 
Furthermore, several small, retrospective studies have shown 
associations of RI with recipient age, intima-media thickness, 
risk for new-onset diabetes mellitus, and hemodynamic factors 
such as the aortic pulse pressure and aortic stiffness, which fur-
ther suggests that the RI is more a representation of the cardio-
vascular status of the recipient.7–10 This is also apparent from a 
study that showed that an increased RI after KTx is associated 
with cardiovascular mortality.11 However, a potential relation-
ship between the postoperative RI and cardiovascular events 
(CVEs) was not further investigated.
While Doppler ultrasound with RI measurement is rou-
tinely performed after KTx, the potential association between 
the early postoperative RI and clinical outcomes has not yet 
been determined. Also, there is no agreement to a standard RI 
in daily medical use or published research: previous studies 
used a cutoff between 0.70 and 0.80, based on the optimal 
cutoff in their specific population.4–6,12
We hypothesized that early postoperative RI measurements 
are influenced by the cardiovascular status of KTx recipients, 
which would result in an association between RI measure-
ments and post-KTx CVEs. Evidence of this association will 
provide a better understanding of RI measurements and sup-
port clinicians with the interpretation. The aim of this study is 
to gain insight in the association between early postoperative 
RI measurements and CVEs, all-cause mortality, and death-
censored graft survival.
MATERIALS AND METHODS
Patients
All adult patients (≥18 y old) who underwent Doppler 
ultrasound with RI measurement directly after KTx at the 
University Medical Center Groningen (UMCG) between 
November 2015 and September 2017 (n = 364) were prospec-
tively included and retrospectively analyzed. Patients were not 
included for further analysis if (a) flow measurements were 
insufficiently reported (n = 18) or (b) patients underwent a 
combined liver-kidney or kidney-pancreas transplantation 
(n = 7), leaving 339 patients eligible for statistical analyses.
Patients’ charts were screened for baseline characteris-
tics. The primary end point was the incidence of CVEs. A 
CVE was defined as the occurrence of a myocardial infarc-
tion (International Statistical Classification of Diseases and 
Related Health Problems [ICD]-10: I21), both ST-elevation 
myocardial infarction (STEMI) and non-ST-elevation myo-
cardial infarction (NSTEMI), unstable angina pectoris 
(ICD-10: I20), a cerebrovascular accident (ICD: I60-I66), a 
transient ischemic attack (ICD-10: G45), or cardiovascular 
death (as death due to one of the afore mentioned circulatory 
conditions).13 Secondary outcomes were (a) all-cause mor-
tality and (b) death-censored graft failure. Graft failure was 
defined as end-stage kidney failure requiring the reinstitution 
of dialysis or a retransplantation. Kidney transplant recipi-
ents who died with a functioning graft were censored at time 
of death. Delayed graft function (DGF) was defined as the 
requirement of dialysis within the first week after transplanta-
tion. Associations were determined for both 1-year outcomes 
and overall follow-up outcomes. To ascertain the incidence of 
CVEs, all-cause mortality, and graft failure, the electronic hos-
pital registry was consulted. In case of inconclusive or miss-
ing follow-up data, the concerning general practitioner was 
approached.
This study was registered in the UMCG research register. 
Due to the descriptive character of this study, our institution’s 
Medical Ethics Committee granted a dispensation for the 
Dutch law regarding patient-based medical research (WMO) 
obligation (Medical Ethical Committee UMCG—201800363). 
Patient data were processed and electronically stored accord-
ing to the Declaration of Helsinki for medical research involv-
ing human subjects. The clinical and research activities were 
consistent with the Principles of the Declaration of Istanbul as 
outlined in the “Declaration of Istanbul on Organ Trafficking 
and Transplant Tourism.”
Doppler Ultrasound
According to hospital protocol, the arterial intrarenal RI 
was measured 3 times (in the upper pole, interpolar, and 
lower pole) within 3 hours after surgery, in each KTx recipi-
ent. These indices were determined in the interlobar or arcu-
ate arteries. The arterial RI was calculated as (peak systolic 
velocity—end-diastolic velocity)/peak systolic velocity. For 
each patient, intrarenal RI was then calculated as mean of 
these 3 measurements. The observation of postoperative per-
inephric fluid collections (hematoma, urinoma, lymphocele) 
and hydronephrosis was based on the description in the post-
operative ultrasound report at time of RI measurement. The 
ultrasound procedure was performed with a curved array 
transducer (multifrequency, 1–6 MHz) on a Toshiba Aplio 
MX (Tokyo, Japan) or Zonare ZS3 (Shenzhen, China) ultra-
sound system.
Statistical Analyses
The RI cutoff for the presented analysis was determined 
using the highest area under the receiver operating character-
istics curve and the Youden Index.14 The Youden Index is a 
statistic that presents the performance of a dichotomous diag-
nostic test and is calculated as (sensitivity of the test + specific-
ity of the test) − 1. Baseline descriptive statistics are presented 
as mean (±SD) or median (interquartile range, IQR) for con-
tinuous variables and counts with percentages for categorical 
variables. Differences in baseline characteristics were tested 
with the unpaired t-test, Mann-Whitney U test, and Chi-
squared test, depending on type and distribution of the data. 
A Kaplan-Meier curve and logrank test were performed to 
identify differences in the incidence of CVE-free survival, 
patient survival, and death-censored graft survival between 
the 2 groups. Univariate Cox regression analyses were per-
formed to calculate hazard ratios (HRs) as estimates of rela-
tive risks. Multivariate Cox proportional hazard regression 
analyses were performed for the calculation of risks, including 
the following predetermined potential explanatory variables: 
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recipient age, gender, body mass index, smoking status, diabe-
tes, preoperative systolic blood pressure and diastolic blood 
pressure (DBP), use of antihypertensive drugs, preoperative 
cholesterol, statin use, pretransplant dialysis, dialysis vintage, 
history of hypertension, history with cardiovascular disease 
(CVD), deceased donation, DGF, and an increased RI. Tests 
with a P value of <0.05 were considered significant. Data 
analysis was performed using IBM SPSS Statistics 23 and 
GraphPad Prism 7.02 for Windows.
RESULTS
Baseline Characteristics
A total of 339 kidney transplant recipients were included. 
At baseline, mean age (±SD) was 54 ± 15 years, and 206 (61%) 
patients were male (Table  1). A preemptive transplantation 
was performed in 101 (30%) recipients. Sixty-eight (20%) 
patients had a history of smoking, and 80 (24%) had experi-
enced prior CVD. The distribution in terms of donor type was 
199 (59%) living kidney donors, 63 (19%) donations after 
brain death, and 77 (23%) donations after circulatory death.
The median time between KTx and RI measurement was 
54 minutes (IQR, 31 min to 1 h 28 min). Mean intrarenal RI 
was 0.64 ± 0.08. For this cohort, an RI value of 0.70 resulted 
in the highest area under the receiver operating characteristics 
curve of 0.77. The cutoff of 0.70 had a higher Youden Index 
compared with a cutoff of, respectively, 0.75 and 0.80 (Youden 
Index of 0.53 compared with 0.18 and 0.12, respectively). We 
stratified our cohort into 2 groups, based on the RI cutoff of 
0.70. A total of 271 (80%) patients had an RI below or equal 
to 0.70, and 68 (20%) had a postoperative RI above 0.70. 
Recipients with an RI > 0.70 were significantly older, were more 
often dialysis dependent, had a lower DBP, and had more often 
a history of diabetes. (Table 1). Donors in the RI > 0.70 group 
were significantly older and more often involved in deceased 
donor transplantation compared with those in the RI ≤ 0.70 
group (Table  1). In univariate linear regression analysis, a 
higher recipient age (ß = 0.28; P < 0.001), a history of diabe-
tes (ß = 0.19; P = 0.001), a history of CVD (ß = 0.12; P = 0.028), 
a lower preoperative DBP (ß = −0.23; P < 0.001), and dialysis 
dependency (ß = 0.20; P < 0.001) were significantly associated 
with a higher RI (Table  2). The following donor variables 
were significantly associated with an increased RI: donor age 
(ß = 0.12; P = 0.030), deceased donation (ß = 0.29; P < 0.001), 
and cold ischemia time (ß = 0.25; P < 0.001).
In the postoperative course, DGF was observed in 58 
(17%) out of 339 recipients, of which 37 out of 271 (14%) in 
the RI ≤ 0.70 group and 21 out of 68 (31%) in the RI > 0.70 
group (P = 0.001). DGF was associated with the RI in linear 
regression (ß = 0.19; P < 0.001). Four (1%) recipients had a 
primary nonfunctioning transplant, of which 3 (1%) in the 
RI ≤ 0.70 group and 1 (1%) in the RI > 0.70 group. At the first 
TABLE 1.
Donor and recipient characteristics
Characteristics Overall, n = 339 RI ≤ 0.70, n = 271 RI > 0.70, n = 68 P
Resistance index 0.64 ± 0.08 0.61 ± 0.06 0.76 ± 0.04  
Recipient     
 Age (y) 54 ± 15 52 ± 15 61 ± 12 <0.001a
 Sex (male) 206 (61%) 159 (59%) 47 (69%) 0.12b
 BMI (kg/m2) 26 ± 4 26 ± 4 26 ± 4 0.65a
 First transplantation 295 (87%) 234 (86%) 61 (90%) 0.46b
 Smoking history 68 (20%) 60 (22%) 8 (12%) 0.061b
 History of diabetes 64 (19%) 38 (14%) 26 (38%) <0.001b
 Hypertension history 198 (58%) 160 (59%) 38 (56%) 0.64b
 CVD history 80 (24%) 61 (23%) 19 (28%) 0.35b
 Preoperative systolic blood pressure 142 ± 21 143 ± 20 145 ± 23 0.48a
 Preoperative diastolic blood pressure 81 ± 13 81 ± 12 78 ± 15 0.041a
 Use of antihypertensive drugs 252 (74%) 200 (74%) 52 (76%) 0.69b
 No. of classes of antihypertensive drugs 1.30 ± 0.91 1.28 ± 0.91 1.37 ± 0.95 0.48a
 Preoperative total cholesterol 4.84 ± 1.04 4.89 ± 0.06 4.62 ± 0.14 0.082a
 Statin use 101 (31%) 80 (30%) 21 (33%) 0.60b
 Prior dialysis 238 (70%) 182 (67%) 56 (82%) 0.012b
 Dialysis vintage (mo) 30 ± 26 31 ± 28 27 ± 17 0.24a
Donor     
 Age (y) 54 ± 13 53 ± 14 57 ± 13 0.017a
 Male sex 182 (54%) 145 (54%) 37 (54%) 0.89b
 Deceased donation 140 (41%) 95 (35%) 45 (66%) <0.001b
 DBD 63 (45%) 42 (44%) 21 (47%) 0.79b
 DCD 77 (55%) 54 (56%) 23 (51%) 0.011b
Perioperative     
 Cold ischemia time (hh:mm) 6:59 ± 5:40 6:24 ± 5:32 9:18 ± 5:39 <0.001a
 First warm ischemia time (min) 6 ± 7 5 ± 7 6 ± 8 0.34a
 Second warm ischemia time (min) 41 ± 13 40 ± 13 43 ± 14 0.24a
aUnpaired t-test.
bChi-squared test.
Data are presented as n (%) or mean ± SD.
BMI, body mass index; CVD, cardiovascular disease; DBD, donation after brain death; DCD, donation after circulatory death; RI, resistance index.
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postoperative ultrasound, 22 (6%) patients had a hematoma, 
of which 18 out of 271 (7%) in the RI ≤ 0.70 group and 4 
out of 68 (6%) in the RI > 0.70 group. One patient had a 
urinoma, and 1 patient had a lymphocele; both were in the 
low RI group. Three patients out of 339 (1%) had postop-
erative hydronephrosis, already present at time of postopera-
tive ultrasound, of which 2 (1%) in the RI ≤ 0.70 group and 1 
(1%) in the RI > 0.70 group.
Cardiovascular Events
In the first postoperative year, 11 (3%) recipients had a 
CVE. The 1-year CVE-free survival was significantly lower 
in patients with an RI > 0.70 compared with patients with 
an RI ≤ 0.70 (respectively, 93% versus 98%; logrank test, 
P = 0.03; Figure 1A). After a median follow-up of 37 months 
(IQR, 33–43), 27 (8%) of the recipients had a CVE: 10 out 
of 68 (15%) patients in the RI > 0.70 group and 17 out of 
271 (6%) patients in the RI ≤ 0.70 group. The distribution of 
first CVEs was as follows: 6 ischemic cerebrovascular inci-
dents, 8 unstable angina pectoris patients with the require-
ment of percutaneous coronary intervention or coronary 
artery bypass grafting, 11 (N)STEMIs, 1 transient ischemic 
attack, and 1 cardiovascular death. Patients with an RI > 0.70 
had worse overall CVE-free survival compared with patients 
with an RI ≤ 0.70 (respectively, 85% versus 94%; logrank 
test, P = 0.008; Figure 2A). Univariate Cox proportional haz-
ard regression revealed that an RI above 0.70 was associated 
with a worse CVE-free survival (HR, 2.79; 95% Confidence 
Interval [CI], 1.27-6.13]; P = 0.011; Table 3). In multivariate 
Cox regression, an RI above 0.70 was associated with CVE-
free survival (HR, 2.48; 95% CI, 1.04-5.96; P = 0.042), inde-
pendent of recipient age, gender, a positive smoking history, 
the use of antihypertensive drugs, a history of CVD, prior 
dialysis, and DGF (Model 5; Table 4). After additional adjust-
ment for deceased donation, the RI was not significantly asso-
ciated with CVE-free survival (HR, 2.08; 95% CI, 0.87-4.98; 
P = 0.10; Model 6; Table 4).
Patient Mortality
In the first postoperative year, 7 (2%) recipients died. In the 
group with an RI > 0.70, 5 out of 68 (7%) patients died com-
pared with 2 out of 271 (1%) patients with an RI ≤ 0.70. The 
1-year patient survival was significantly lower in patients with 
an RI > 0.70 compared with patients with an RI ≤ 0.70 (respec-
tively, 93% versus 99%; logrank test, P = 0.001; Figure 1B). 
After a median follow-up of 37 months, 27 patients (8%) 
died, of whom 5 (19%) died from CVD. Of these 27 events, 
10 (15%) occurred in the RI > 0.70 group, and 17 (6%) 
occurred in the RI ≤ 0.70 group. Patients with an RI > 0.70 had 
significantly worse overall survival compared with patients 
with an RI ≤ 0.70 (respectively, 85% versus 94%; logrank 
test, P = 0.013; Figure 2B). Univariate Cox proportional haz-
ard regression showed that an RI above 0.70 is significantly 
associated with a worse overall patient survival (HR, 2.69; 
95% CI, 1.18-5.65; P = 0.017; Table 3). In multivariate Cox 
regression analysis, the association between patient survival 
and an RI above 0.70 was not significant after adjustment for 
recipient age and gender (Model 2; Table 4).
Death-censored Graft Survival
Fourteen (4%) patients developed graft failure in the 
first postoperative year, of which 3 out of 68 (4%) patients 
with an RI > 0.70 and 11 out of 271 (4%) patients with an 
TABLE 2.
Linear regression with patient characteristics and the 
resistance index
 
Resistance index
β-coefficient t-value P
Recipient    
 Age recipient (y) 0.28 5.42 <0.001*
 Sex recipient (female) −0.06 −1.14 0.26
 BMI recipient (kg/m2) 0.05 0.86 0.39
 Smoking history −0.14 −0.25 0.80
 History of diabetes 0.19 3.47 0.001*
 History of cardiovascular disease 0.12 2.20 0.028*
 Preoperative systolic blood pressure 0.03 0.60 0.55
 Preoperative diastolic blood pressure −0.23 −4.26 <0.001*
 Use of antihypertensive drugs −0.11 −0.20 0.84
 No. of classes of antihypertensive drugs −0.21 −0.36 0.72
 Preoperative total cholesterol 0.04 0.66 0.51
 Statin use −0.06 −1.16 0.25
 Prior dialysis 0.20 3.74 <0.001*
 Dialysis vintage (mo) −0.03 −0.44 0.66
Donor    
 Age donor 0.12 2.18 0.030*
 Sex donor (female) −0.11 −0.19 0.85
 Type of donation (deceased) 0.29 5.62 <0.001*
Perioperative    
 Cold ischemia time (h) 0.25 4.78 <0.001*
 First warm ischemia time (min) 0.06 1.09 0.28
 Second warm ischemia time (min) −0.001 −0.12 0.99
 Delayed graft function 0.19 3.61 <0.001*
*P < 0.05.
BMI, body mass index.
A B C
FIGURE 1. Kaplan-Meier curves of 1-y CVE-free survival, 1-y patient survival, and 1-y death-censored graft survival. CVEs, cardiovascular 
events; RI, resistance index.
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RI ≤ 0.70. The 1-year death-censored graft survival did not 
differ between the groups (both 96%; logrank test, P = 0.88; 
Figure 1C). After a median follow-up of 37 months, 17 (5%) 
recipients developed graft failure, of which 4 (6%) patients 
in the RI > 0.70 group and 13 (5%) patients in the RI ≤ 0.70 
group. The causes of graft failure were as follows: 3 acute 
rejection, 6 chronic rejection, 2 venous thromboses, 2 recur-
rences of underlying disease, 2 tubular ischemia, 1 thrombotic 
microangiopathy, and 1 diabetic nephropathy. The death-cen-
sored graft survival did also not differ between the groups 
on overall follow-up (RI ≤ 0.70: 95% versus RI > 0.70: 94%; 
logrank test, P = 0.65; Figure 2C). The RI was not associated 
with overall death-censored graft survival in univariate Cox 
regression analysis (HR, 1.29; 95% CI, 0.42-3.97; P = 0.65).
DISCUSSION
This study showed that KTx recipients with a postopera-
tive RI above 0.70 had a worse CVE-free survival and low-
ered patient survival after 1-year and overall follow-up. We 
could not demonstrate any differences in death-censored 
graft survival between the 2 groups. Moreover, we found 
that an RI above 0.70 in the multivariate Cox regression 
analysis without inclusion of deceased donation was inde-
pendently associated with a worse CVE-free survival after 
transplantation, whereas this independent association was 
not found with overall patient survival and the risk of graft 
failure. These findings support the hypothesis that early 
postoperative RI measurements are associated with, or 
even a representation of, the cardiovascular status of KTx 
recipients.
Doppler ultrasound is a noninvasive, safe, and relatively 
cheap imaging tool. Due to the KDIGO recommendation to 
evaluate the transplanted kidney with ultrasound, Doppler 
ultrasound is routinely performed after kidney transplan-
tation.3 Therefore, measuring the RI leads not to a higher 
patient burden but will provide the opportunity as early risk 
marker for CVEs and possibly patient mortality. But where 
the KDIGO recommendation falls short is giving an evidence-
based cutoff, for example, for advising on a surgical reinter-
vention or a patient-specific/personalized follow-up. The lack 
of a clear flowchart on how to interpret the duplex results, 
except for the gross information on perfusion or hematomas, 
restricts a wider implementation, especially when it is becom-
ing clear that Doppler ultrasound data have information of 
both the graft and the recipient, which may provide informa-
tion for patient-specific/personalized follow-up.
Our study is in line with a study that detected an increased 
risk of cardiovascular mortality in patients with an increased 
RI in the posttransplant period.11 In this study, the RI was 
more associated with cardiovascular death than overall death. 
With only 5 patients dying from CVD in our study, we were 
unable to reproduce these results. The association between 
patients’ cardiovascular state and the RI is possibly caused 
by the underlying mechanism of increased arterial stiffness in 
patients with worse cardiovascular risk profiles. An increase 
in a higher mean arterial pressure leads to the recruitment 
of inelastic collagen fibers.15 The increase in inelastic collagen 
fibers leads to an increased arterial stiffness (or decrease in 
compliance), which causes a relative increase of the systolic 
blood pressure and a relative decrease of the DBP, resulting in 
an increased RI.9,16
In accordance with a large prospective study, we found 
associations between the RI and donor age, deceased dona-
tion, and cold ischemia time.4 However, we found no associa-
tions between the RI and graft survival.4 In that study, a high 
RI was associated with the requirement of dialysis. However, 
an extensive variation in time of Doppler ultrasound perfor-
mance was used, ranging from 3 to 317 months. The enrolled 
patients could therefore have been transplanted within a time 
interval of a few months to many years. Interestingly, the time 
after transplantation in patients with a high RI was signifi-
cantly higher (6.6 ± 5.5 versus 4.6 ± 4.6 y). The time elapsed 
after transplantation has proven to be a major determinant of 
the predictive value of the RI in predicting allograft failure or 
recipient death.17 These factors may have led to the associa-
tion between the RI and the decline in graft function in this 
particular study but also ensure that the short-term effect can-
not be assessed. In our study, the variation in time between 
transplant and measurement is very limited; RI measurements 
were performed within 3 hours after transplantation.
We showed that patients with a higher RI were older, 
had more often diabetes, and were more frequently dialysis 
dependent, all factors known to lead to a worse cardiovas-
cular state.18 Various smaller studies reported associations 
between the RI and recipient characteristics, such as age, sys-
tolic and DBP, pulse pressure, aortic stiffness, smoking status, 
and abdominal aortic calcifications and the carotid intima-
media thickness.7–9 This, in combination with our results, cre-
ates important evidence that an increased postoperative RI is 
a reflection of cardiovascular burden instead of only a marker 
for the condition or microperfusion of the graft parenchyma. 
The RI was not significantly associated with CVE-free survival 
after inclusion of deceased donation in the final multivariate 
Cox regression model. This could be explained by the over 
all better patient and graft outcomes of living kidney donor 
transplantation compared with deceased donation, which can 
be partly explained by the high number of preemptive KTx 
A B C
FIGURE 2. Kaplan-Meier curves of overall CVE-free survival, overall patient survival, and overall death-censored graft survival. CVEs, 
cardiovascular events; RI, resistance index.
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recipients undergoing living kidney donor transplantation.19 
To reliably establish the effect of RI on graft function, studies 
should focus on the alteration of the RI in the postoperative 
setting, given the scarce and somewhat contradictory evidence 
on the prediction of renal allograft function or graft loss with 
just a single RI measurement. With the information that the 
RI may fluctuate during follow-up and that this change can 
be predictive for graft function, this simple and cheap new 
tool can be added to our armamentarium in monitoring and 
adjusting the posttransplant course.17,20
Some limitations of the present study need to be addressed. 
First, the postoperative RI measurement was performed by 
the Radiology clinician on call, instead of 1 dedicated radi-
ologist. The effect of this limitation on the presented results 
is considered minimal, in light of the low intraobserver and 
interobserver variability (<5%) found in the literature.4,5 
Second, the incidence of CVEs in our study can be considered 
low, with a CVE in 8% of patients after a median follow-up 
of 37 months. The numbers are comparable to the MECANO 
study, a prospective clinical trial in the Dutch transplant pop-
ulation, which reported an incidence of cardiovascular events 
of 11% after 7 years.21 The design of this study creates the risk 
of an underestimation of the total number of CVEs, due to 
underreporting from follow-up centers despite the additional 
information that was obtained from the general practitioner.
Third, the relatively small number of patients and subse-
quent events left open the possibility of either a type 1 or type 
2 bias. Finally, this study was conducted in a single center. 
The population of the study consists of relatively young trans-
plant recipients, with a relatively high rate of living donors. 
TABLE 3.
Univariate Cox regression analysis on overall CVEs and all-cause mortality
 
 
Univariate analysis
CVEs All-cause mortality
HR 95% CI P HR 95% CI P
Age recipient (y) 1.03 1.00-1.07 0.095 1.05 1.02-1.09 0.003*
Sex recipient (female) 0.64 0.28-1.45 0.28 0.43 0.17-1.06 0.051
BMI recipient, kg/m2 1.05 0.97-1.14 0.25 1.02 0.93-1.11 0.69
Smoking history 1.49 0.63-3.52 0.37 1.20 0.48-2.98 0.69
History of diabetes 1.40 0.56-3.48 0.47 2.74 1.26-5.99 0.011*
Preoperative SBP 1.02 1.00-1.03 0.076 1.01 1.00-1.03 0.14
Preoperative DBP 1.01 0.98-1.04 0.48 0.98 0.95-1.01 0.14
Use of AH drugs 1.84 0.63-5.33 0.26 0.64 0.29-1.43 0.28
Preoperative cholesterol 1.34 0.93-1.93 0.12 1.00 0.67-1.49 0.99
Statin use 0.83 0.35-1.97 0.68 2.22 0.75-6.51 0.15
Prior dialysis 1.50 0.60-3.71 0.38 5.36 1.27-22.62 0.022*
Dialysis vintage (mo) 1.00 0.98-1.02 0.79 1.00 0.99-1.02 0.99
History of CVD 1.48 0.65-3.38 0.35 2.06 0.94-4.50 0.070
History of hypertension 1.68 0.74-3.85 0.22 1.02 0.47-2.20 0.96
Type of donation (DD) 4.38 1.85-10.36 0.001* 2.21 1.02-4.78 0.043*
Delayed graft function 1.70 0.72-4.03 0.23 2.05 0.87-4.68 0.089
Resistance index > 0.70 2.79 1.27-6.13 0.011* 2.59 1.18-5.65 0.017*
*P < 0.05. AH, antihypertensive; BMI, Body Mass Index; CI, confidence interval; CVD, cardiovascular disease; CVEs, cardiovascular events; DBP, diastolic blood pressure; DD, deceased donation; HR, 
hazard ratio; SBP, systolic blood pressure.
TABLE 4.
Multivariate Cox regression analysis on overall CVE’s and all-cause mortality
 
 
Multivariate analysis
CVEs All-cause mortality
HR (95% CI) P HR (95% CI) P
Model 1 2.79 1.27-6.13 0.011* 2.59 1.18-5.65 0.017*
Model 2 2.39 1.06-5.38 0.036* 1.85 0.83-4.12 0.13
Model 3 2.56 1.11-5.84 0.028* 2.02 0.90-4.54 0.088
Model 4 2.53 1.07-5.97 0.035* 1.84 0.81-4.22 0.15
Model 5 2.48 1.04-5.96 0.042* 1.85 0.80-4.25 0.15
Model 6 2.08 0.87-4.98 0.10 1.94 0.84-4.51 0.12
*P < 0.05.
Model 1: crude.
Model 2: adjusted for recipient age and recipient gender.
Model 3: adjusted for model 2 + history of smoking and antihypertensive drugs use.
Model 4: adjusted for model 3 + history of cardiovascular disease and prior dialysis.
Model 5: adjusted for model 4 + delayed graft function.
Model 6: adjusted for model 4 + deceased donation.
CI, confidence interval; CVEs, cardiovascular events; HR, hazard ratio; RI, resistance index.
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The presented results are not necessarily generalizable to KTx 
recipients from centers with different populations. However, 
the current study population corresponds to the average Dutch 
KTx population at this time point.21 Another important factor 
that should be addressed is the used cutoff value of the RI. In 
the literature, the RI cutoff varies from 0.70 to 0.80.4–6,12 This 
variation is probably caused by (a) the method of measuring 
the RI, for example, different ultrasound machines or (b) a 
different patient population. Multiple RI cutoff values should 
be evaluated to establish the optimal RI cutoff value that 
maximizes the generalizability and thereby the clinical value 
of the RI. This should ideally be incorporated into national 
and international recommendations or guidelines.
In conclusion, a postoperative RI above 0.70 is associated 
with worse CVE-free survival and to a lesser extent, patient 
survival. Evidence of this association provides a better under-
standing of RI outcomes, which can support clinicians with 
the interpretations of the RI. The cardiovascular status of 
KTx recipients should be included in the clinical interpreta-
tion of early postoperative RI outcomes and follow-up.
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